CHICAGO, June 24, 2025 /PRNewswire/ -- Bridge to Life™ Ltd., a leader in organ preservation solutions and perfusion technology, today announced that the U.S. Food and Drug Administration has granted ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果